sroberts on PROD1PC70 with NOTICES

2076 Federal Register / Vol. 74, No. 9 / Wednesday, January 14, 2009 / Notices 

Audio conferencing will be available for 

the second day of the meeting. 

DATES: The meeting will be held on 

February 5, 2009, from 8:30 a.m. to 6:30 

p.m. and on February 6, 2009, from 8 

a.m. to 3:30 p.m. 

ADDRESSES: Department of Health and 

Human Services; Hubert H. Humphrey 

Building, Room 800; 200 Independence 

Avenue, SW., Washington, DC 20201. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Andrea Krull, National Vaccine Program 

Office, Department of Health and 

Human Services, Room 443-H, Hubert 

H. Humphrey Building, 200 

Independence Avenue, SW., 

Washington, DC 20201. Phone: (202) 

690–5566; Fax: (202) 260–1165; e-mail: 

nvpo@hhs.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to Section 2101 of the Public Health 

Service Act (42 U.S.C. Section 300aa-1), 

the Secretary of Health and Human 

Services was mandated to establish the 

National Vaccine Program to achieve 

optimal prevention of human infectious 

diseases through immunization and to 

achieve optimal prevention against 

adverse reactions to vaccines. The 

National Vaccine Advisory Committee 

was established to provide advice and 

make recommendations to the Director 

of the National Vaccine Program, on 

matters related to the Program’s 

responsibilities. The Assistant Secretary 

for Health serves as Director of the 

National Vaccine Program. 

Topics to be discussed at the meeting 

on Thursday, February 5, 2009 include 

vaccine financing, vaccine safety, 

vaccine stockpile, seasonal influenza 

and related issues, vaccine 

development, and the National Vaccine 

Plan. Updates will be given by the 

NVAC Financing, Adult Immunization, 

and Safety working groups. The meeting 

on Friday, February 6, 2009 is a full day 

stakeholders’ meeting to discuss the 

draft strategic National Vaccine Plan. 

The draft plan can be viewed at the 

following Web site: http://www.hhs.gov/ 

nvpo/vacc_plan/. The meeting will 

begin with a plenary session to provide 

an overview of the day’s agenda 

followed by break-out sessions for each 

of the five draft strategic National 

Vaccine Plan goals. Audio-conferencing 

will be available for the stakeholders’ 

meeting on February 6, 2009 for the 

plenary as well as break-out sessions. 

Call-in numbers for the meeting are as 

follows: plenary sessions on February 6: 

(888) 390–3413 (passcode: 60302); goal 

1: research (888) 469–1340 (passcode 

27271); goal 2: safety (888) 989–4406 

(passcode 41520); goal 3: 

communication (800) 779–6844 

(passcode 19562); goal 4: supply (888) 

994–8791 (passcode 37886); and goal 5: 

global health (888) 989–4717 (passcode 

12377). Agendas for each day of the 

meeting will be posted on the NVAC 

Web site: www.hhs.gov/nvpo/nvac by 

January 21, 2009. 

Public attendance at the meeting is 

limited to space available. Individuals 

who plan to attend and need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify the 

designated contact person at least one 

week prior to the meeting. Members of 

the public will have the opportunity to 

provide comments at the meeting. 

Public comment will be limited to five 

minutes per speaker. Individuals who 

would like to submit written statements 

should e-mail or fax their comments to 

the National Vaccine Program Office at 

least five business days prior to the 

meeting. A separate Federal Register 

Notice will be issued with detailed 

instructions for submitting comments 

about the draft strategic National 

Vaccine Plan. Any members of the 

public who wish to have printed 

material distributed to NVAC members 

should submit materials to the 

Executive Secretary, NVAC, through the 

contact person listed above prior to 

close of business January 30, 2009. 

Dated: January 5, 2009. 

Bruce Gellin, 

Deputy Assistant Secretary for Health, 

Director, National Vaccine Program Office. 

[FR Doc. E9–498 Filed 1–13–09; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institute for Occupational 

Safety and Health; Decision To 

Evaluate a Petition To Designate a 

Class of Employees for the Piqua 

Organic Moderated Reactor Site, 

Piqua, Ohio, To Be Included in the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice as required 

by 42 CFR 83.12(e) of a decision to 

evaluate a petition to designate a class 

of employees for the Piqua Organic 

Moderated Reactor site, Piqua, Ohio, to 

be included in the Special Exposure 

Cohort under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. The initial 

proposed definition for the class being 

evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Piqua Organic Moderated 

Reactor site. 

Location: Piqua, Ohio. 

Job Titles and/or Job Duties: All 

employees associated with reactor 

activities who worked within and 

around the Reactor Dome. 

Period of Employment: January 1, 

1963 through December 31, 1966. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 4676 Columbia 

Parkway, MS C–46, Cincinnati, OH 

45226, Telephone 513–533–6800 (this is 

not a toll-free number). Information 

requests can also be submitted by e-mail 

to OCAS@CDC.GOV. 

Dated: January 6, 2009. 

Christine M. Branche, 

Acting Director, National Institute for 

Occupational Safety and Health. 

[FR Doc. E9–571 Filed 1–13–09; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Solicitation of Written Comments on 

Draft Strategic National Vaccine Plan 

AGENCY: Department of Health and 

Human Services, Office of the Secretary. 

ACTION: Notice. 

SUMMARY: On behalf of the National 

Vaccine Advisory Committee (NVAC), 

the National Vaccine Program Office 

(NVPO) is soliciting public comment on 

the draft strategic National Vaccine 

Plan. 

DATES: All comments on the draft 

strategic National Vaccine Plan should 

be received no later than 5 p.m. on 

January 30, 2009. 

ADDRESSES: Electronic responses are 

preferred and may be addressed to 

NVPComments@hhs.gov. Written 

responses should be addressed to 

National Vaccine Program Office, 

Department of Health and Human 

Services, 200 Independence Avenue, 

SW., Room 443–H, Washington, DC 

20201, Attention: National Vaccine Plan 

RFI. 

FOR FURTHER INFORMATION CONTACT: 

CAPT Raymond A. Strikas, M.D., 

National Vaccine Program Office, 

Department of Health and Human 

Services, 200 Independence Avenue, 

SW., Room 443–H, Washington, DC 

20201; (202) 690–5566; fax 202–260– 

1165; e-mail nvpo@hhs.gov. 

SUPPLEMENTARY INFORMATION: